Problems with measuring the use of beta-blockers in ambulatory settings for secondary prevention in patients with coronary artery disease.
Kakaiya
R
R
Wamhoff
J
J
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000553:Ambulatory Care; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D015986:Confounding Factors, Epidemiologic; D003327:Coronary Disease / Q000517:prevention & control*; D004363:Drug Utilization / Q000706:statistics & numerical data; D006801:Humans; D012008:Recurrence; D012107:Research Design; D014481:United States
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors